Matches in SemOpenAlex for { <https://semopenalex.org/work/W1550813904> ?p ?o ?g. }
- W1550813904 endingPage "539" @default.
- W1550813904 startingPage "524" @default.
- W1550813904 abstract "Dapoxetine has been evaluated for the on-demand treatment of premature ejaculation (PE) in five phase 3 studies in various populations worldwide and has recently been approved in several countries.To present integrated efficacy and safety data from phase 3 trials of dapoxetine.Data were from five randomized, multicenter, double-blind, placebo-controlled studies conducted in over 25 countries. Men (N=6,081)≥18 years who met the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision criteria for PE; four studies required a baseline intravaginal ejaculatory latency time (IELT) of ≤2 minutes. Dapoxetine 30 and 60 mg on demand (prn; 1-3 hours before intercourse) were evaluated for either 12 or 24 weeks in four studies; one study evaluated dapoxetine 60 mg daily (qd; included in safety assessments only) or prn for 9 weeks.End points included stopwatch-measured IELT, Premature Ejaculation Profile (PEP) items, clinical global impression of change (CGIC) in PE, and adverse events (AEs).Average IELT (mean [standard deviation], geometric mean [standard error]) increased from baseline (across groups, 0.9 [0.49] minutes, 0.8 [1.01] minutes) to a significantly greater extent with dapoxetine 30 (3.1 [3.91] minutes, 2.0 [1.03] minutes) and 60 mg (3.6 [3.85] minutes, 2.3 [1.03] minutes) vs. placebo (1.9 [2.43] minutes, 1.3 [1.02] minutes; P<0.001 for all) at week 12 (geometric mean fold increase, 2.5, 3.0, and 1.6, respectively). All PEP items and CGIC improved significantly with both doses of dapoxetine vs. placebo (P<0.001 for all). The most common AEs included nausea, dizziness, and headache, and evaluation of validated instruments demonstrated no anxiety, akathisia, suicidality, or changes in mood with dapoxetine use and no discontinuation syndrome following abrupt withdrawal.In this diverse population, dapoxetine significantly improved all aspects of PE and was generally well tolerated." @default.
- W1550813904 created "2016-06-24" @default.
- W1550813904 creator A5012643629 @default.
- W1550813904 creator A5017226768 @default.
- W1550813904 creator A5019579312 @default.
- W1550813904 creator A5020814991 @default.
- W1550813904 creator A5027291293 @default.
- W1550813904 creator A5028584696 @default.
- W1550813904 creator A5031260299 @default.
- W1550813904 creator A5044773689 @default.
- W1550813904 creator A5054919199 @default.
- W1550813904 creator A5088486376 @default.
- W1550813904 date "2011-02-01" @default.
- W1550813904 modified "2023-09-30" @default.
- W1550813904 title "Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 Trials" @default.
- W1550813904 cites W1578821518 @default.
- W1550813904 cites W1963668189 @default.
- W1550813904 cites W1967559575 @default.
- W1550813904 cites W1970299603 @default.
- W1550813904 cites W1979070058 @default.
- W1550813904 cites W1981160225 @default.
- W1550813904 cites W1988612597 @default.
- W1550813904 cites W1994620235 @default.
- W1550813904 cites W1997828292 @default.
- W1550813904 cites W2000142370 @default.
- W1550813904 cites W2000640050 @default.
- W1550813904 cites W2007635158 @default.
- W1550813904 cites W2015744471 @default.
- W1550813904 cites W2022191212 @default.
- W1550813904 cites W2023441406 @default.
- W1550813904 cites W2024273281 @default.
- W1550813904 cites W2026262479 @default.
- W1550813904 cites W2032519777 @default.
- W1550813904 cites W2038826787 @default.
- W1550813904 cites W2050404971 @default.
- W1550813904 cites W2058554972 @default.
- W1550813904 cites W2061870162 @default.
- W1550813904 cites W2062093131 @default.
- W1550813904 cites W2070486940 @default.
- W1550813904 cites W2089876800 @default.
- W1550813904 cites W2090977130 @default.
- W1550813904 cites W2101081991 @default.
- W1550813904 cites W2102716890 @default.
- W1550813904 cites W2103258186 @default.
- W1550813904 cites W2103622241 @default.
- W1550813904 cites W2109018621 @default.
- W1550813904 cites W2109657386 @default.
- W1550813904 cites W2131823335 @default.
- W1550813904 cites W2134401797 @default.
- W1550813904 cites W2137898665 @default.
- W1550813904 cites W2142312342 @default.
- W1550813904 cites W2143484005 @default.
- W1550813904 cites W2145619691 @default.
- W1550813904 cites W2157800706 @default.
- W1550813904 cites W2160070901 @default.
- W1550813904 cites W2167725431 @default.
- W1550813904 cites W4242616751 @default.
- W1550813904 cites W4297679875 @default.
- W1550813904 doi "https://doi.org/10.1111/j.1743-6109.2010.02097.x" @default.
- W1550813904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21059176" @default.
- W1550813904 hasPublicationYear "2011" @default.
- W1550813904 type Work @default.
- W1550813904 sameAs 1550813904 @default.
- W1550813904 citedByCount "131" @default.
- W1550813904 countsByYear W15508139042012 @default.
- W1550813904 countsByYear W15508139042013 @default.
- W1550813904 countsByYear W15508139042014 @default.
- W1550813904 countsByYear W15508139042015 @default.
- W1550813904 countsByYear W15508139042016 @default.
- W1550813904 countsByYear W15508139042017 @default.
- W1550813904 countsByYear W15508139042018 @default.
- W1550813904 countsByYear W15508139042019 @default.
- W1550813904 countsByYear W15508139042020 @default.
- W1550813904 countsByYear W15508139042021 @default.
- W1550813904 countsByYear W15508139042022 @default.
- W1550813904 countsByYear W15508139042023 @default.
- W1550813904 crossrefType "journal-article" @default.
- W1550813904 hasAuthorship W1550813904A5012643629 @default.
- W1550813904 hasAuthorship W1550813904A5017226768 @default.
- W1550813904 hasAuthorship W1550813904A5019579312 @default.
- W1550813904 hasAuthorship W1550813904A5020814991 @default.
- W1550813904 hasAuthorship W1550813904A5027291293 @default.
- W1550813904 hasAuthorship W1550813904A5028584696 @default.
- W1550813904 hasAuthorship W1550813904A5031260299 @default.
- W1550813904 hasAuthorship W1550813904A5044773689 @default.
- W1550813904 hasAuthorship W1550813904A5054919199 @default.
- W1550813904 hasAuthorship W1550813904A5088486376 @default.
- W1550813904 hasConcept C11171543 @default.
- W1550813904 hasConcept C126322002 @default.
- W1550813904 hasConcept C142724271 @default.
- W1550813904 hasConcept C15744967 @default.
- W1550813904 hasConcept C197934379 @default.
- W1550813904 hasConcept C204787440 @default.
- W1550813904 hasConcept C27081682 @default.
- W1550813904 hasConcept C2776000289 @default.
- W1550813904 hasConcept C2777812360 @default.
- W1550813904 hasConcept C2779892816 @default.
- W1550813904 hasConcept C42219234 @default.